---
title: "Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NKTR Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288622904.md"
description: "Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NKTR Stock News"
datetime: "2026-06-03T12:15:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288622904.md)
  - [en](https://longbridge.com/en/news/288622904.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288622904.md)
---

# Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NKTR Stock News

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NKTR Stock News

### Related Stocks

- [NKTR.US](https://longbridge.com/en/quote/NKTR.US.md)

## Related News & Research

- [Is Nektar (NKTR) Betting Its Immunology Future on Rezpegaldesleukin’s Ambitious ZENITH-AD Phase 3 Program?](https://longbridge.com/en/news/289087155.md)
- [Is Dover Stock Underperforming the Nasdaq?](https://longbridge.com/en/news/289608765.md)
- [AI IPO boom poses revenue reality risks for investors](https://longbridge.com/en/news/289211373.md)
- [Insider Buying: Medline (NASDAQ:MDLN) Insider Acquires 5,000 Shares of Stock](https://longbridge.com/en/news/289238679.md)
- [FCHL Receives Nasdaq Deficiency Notice on May 26, 2026 | FCHL Stock News](https://longbridge.com/en/news/288123506.md)